Vimarsana
Biggest News Aggregation in the World

Page 25 - Sciences Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sciences Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sciences Ltd Today - Breaking & Trending Today

Seed Innovations Ltd hails progress at investee Little Green Pharma - Vimarsana News

Seed Innovations Ltd hails progress at investee Little Green Pharma

Seed Innovations Ltd hailed the performance of 3.1%-owned portfolio company Little Green Pharma Ltd (ASX:LGP) (LGP), which increased revenue 30% to...

Zacks: Analysts Expect Myovant Sciences Ltd. (NYSE:MYOV) Will Post Quarterly Sales of $60.06 Million - Vimarsana News

Zacks: Analysts Expect Myovant Sciences Ltd. (NYSE:MYOV) Will Post Quarterly Sales of $60.06 Million

Brokerages expect that Myovant Sciences Ltd. (NYSE:MYOV – Get Rating) will announce sales of $60.06 million for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for Myovant Sciences’ earnings. The lowest sales estimate is $55.50 million and the highest is $64.62 million. Myovant Sciences reported sales of $24.61 million in the […]

Roivant Sciences Ltd. (NASDAQ:ROIV) Given Average Rating of "Buy" by Brokerages - Vimarsana News

Roivant Sciences Ltd. (NASDAQ:ROIV) Given Average Rating of "Buy" by Brokerages

Shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Get Rating) have been assigned an average rating of “Buy” from the eight ratings firms that are covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating and seven have assigned a buy rating to the company. The average 1-year price […]

Roivant Sciences Ltd. (NASDAQ:ROIV) Given Consensus Recommendation of "Buy" by Brokerages - Vimarsana News

Roivant Sciences Ltd. (NASDAQ:ROIV) Given Consensus Recommendation of "Buy" by Brokerages

Shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Get Rating) have been assigned an average recommendation of “Buy” from the eight brokerages that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating and seven have assigned a buy rating to the company. The average 1-year target price […]

Myovant Sciences Ltd. (NYSE:MYOV) Insider Ferreira Juan Camilo Arjona Sells 4,632 Shares - Vimarsana News

Myovant Sciences Ltd. (NYSE:MYOV) Insider Ferreira Juan Camilo Arjona Sells 4,632 Shares

Myovant Sciences Ltd. (NYSE:MYOV – Get Rating) insider Ferreira Juan Camilo Arjona sold 4,632 shares of the company’s stock in a transaction on Tuesday, April 19th. The stock was sold at an average price of $10.45, for a total value of $48,404.40. Following the transaction, the insider now owns 260,129 shares in the company, valued […]